RecruitingNCT06774339

Biomarkers and Inflammation in Solid Organ Transplantation: Relationship With Short- and Long-Term Outcomes

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

250 participants

Start Date

Oct 10, 2024

Study Type

OBSERVATIONAL

Conditions

Solid-organ Transplantation

Summary

This is a prospective, tissue-based, low-risk, non-pharmacological study that will include adult patients undergoing solid organ transplantation (heart, liver, lung, kidney) followed at the following Units of the IRCCS Azienda Ospedaliero-Universitaria di Bologna (IRCCS AOUBO): * Heart Failure and Transplants (heart-lung) * Internal Medicine for the Treatment of Severe Organ Failures (liver) * Nephrology, Dialysis, and Transplantation (kidney).

Eligibility

Min Age: 18 Years

Inclusion Criteria2

Adult patients (≥ 18 years old at the time of enrollment) who have undergone at least one of the following: Liver transplant, Kidney transplant, Heart transplant, Lung transplant during the study period.
Informed consent acquisition.